Cancer Supportive Care Therapeutics Market 10-Year Market Forecast and Trends Analysis Research Report
Request Sample Copy of the Report@
Cancer supportive care therapeutics is an emerging trend in cancer treatment as it significantly due to rapid increases drug discovery and development process for therapeutics which are able to decrease the after-effects of complication arising during and after cancer treatment in an individual thus assisting in increasing the life expectancy of cancer patients. Increasing awareness and collaboration by leading organizations to promote cancer supportive care programs is expected to drive the market during the forecast period. For instance, in 2007, the National Palliative Care Research Center and the American Cancer Society invested in palliative care and symptom management to improve the quality of life of cancer patients and survivors. The collaboration also aimed at increasing research activity in cancer palliative care.
The European Society for Medical Oncology has proposed a set of clinical guidelines which are a set of recommendations for cancer care. These guideline address the management of anticancer therapy, febrile neutropenia, prevention of chemotherapy and radiotherapy-induced nausea and vomiting, treatment of dyspnea in advance cancer stages, oral and gastrointestinal mucosal injury, advanced care planning in palliative care, bone health, and other cancer supportive care. The global cancer supportive care therapeutics market has been segmented based on drug type, indication type, distribution channel, and region. In terms of drug type, the market has been segmented into allopurinol, rasburicase, amifostine, colony-stimulating factors, and others. Based on indication type, the market has been classified into cancer pain, chemotherapy-induced anemia, chemotherapy induced neutropenia, chemotherapy-induced nausea & vomiting, oral mucositis, and bone metastasis. In terms of distribution channel, the cancer supportive care therapeutics market has been classified into hospital pharmacies, retail pharmacies, and e-commerce.
Major drivers of the cancer supportive care therapeutics market are increasing prevalence of cancer disease, rapidly developing biopharmaceutical industry, rising academic & clinical research activity, increasing collaboration between organizations to spread awareness, changing lifestyle, advancements in the health care industry, launch of novel therapeutics, and increasing per capita income in emerging markets. Increasing growth in the biopharmaceutical industry has resulted in major advancement in cancer research and treatment. Developments in drug discovery have resulted in decreased mortality rates among cancer patients. There have been major improvements in cancer pain management; however, these improvements have been underutilized due to poor assessment by physicians and lack of adequate knowledge of newer drugs and treatment. Lack of awareness about different therapeutics used during cancer supportive care in emerging economies, high cost of treatment, rigid government regulation, and unfavorable reimbursement rates are the major restraints of the cancer supportive care therapeutics market.
Geographically, the global cancer supportive care therapeutics market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America leads the cancer supportive care therapeutic market due of increasing population, rising patient pool, growing geriatric population, increasing number of screening procedures, presence of leading manufacturers, and technological advancements. North America is closely followed by Europe and Asia Pacific. Asia Pacific is an emerging market for cancer supportive care therapeutics primarily because of increasing health care expenditure in the region, rising population, and growing awareness.
Key players in the global spasticity treatment market are Amgen, Inc., Bayer AG, Daiichi Sankyo Company Limited, Pfizer, Inc., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Depomed, Inc., Eli Lilly and Company, and Merck & Co., Inc., among others.
Request TOC of the Report@
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics
Supply and demand
Value chain and stakeholder analysis
The regional analysis covers:
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Supportive Care Therapeutics Market 10-Year Market Forecast and Trends Analysis Research Report here
News-ID: 727273 • Views: 262
More Releases from Transparency Market Research
Potassium Bicarbonate Market Technological breakthroughs, Value chain and stakeh …
Overview TMR’s report on the Potassium Bicarbonate Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Potassium Bicarbonate serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Potassium Bicarbonate over the forecast period. These indicators help businesses
Liquid Analytical Instruments Market Global Market Opportunity Assessment Study …
Overview TMR’s report on the Liquid Analytical Instruments Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Liquid Analytical Instruments serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Liquid Analytical Instruments over the forecast period. These
Boron Oxide Market Growth Prospects, Trends and Forecast up to 2023
Overview TMR’s report on the Boron Oxide Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Boron Oxide serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Boron Oxide over the forecast period. These indicators help businesses
Hydrochloric Acid Market to Witness a Pronounce Growth During 2016 - 2024
Overview TMR’s report on the Hydrochloric Acid Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Hydrochloric Acid serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Hydrochloric Acid over the forecast period. These indicators help businesses
More Releases for Cancer
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and